Description For Your Fourth Milestone In Your Final Project ✓ Solved
Descriptionfor Your Fourth Milestone In Your Final Project
For your fourth milestone in your final project, you will provide an in-depth analysis of the key elements related to your chosen issue (IMMUNIZATION). Your analysis of the issue should build on your Milestone Three outline and address the following elements:
- Analyze the needs and interests of the key stakeholders you identified. Be sure to provide specific examples.
- Apply current healthcare laws, policies, and financing practices to the issue. Be sure to highlight any potential financial ramifications associated with the issue.
- Explain why stakeholder value conflicts may exist in this environment. Be sure to justify your reasoning.
- Evaluate the legal risks and malpractice issues you identified in Milestone Two, being sure to analyze how conflicting values may impact potential legal risks.
Guidelines for Submission: Your analysis should be 2 to 4 pages in length. It should be formatted in 12-point Times New Roman font, double-spaced, with one-inch margins. All citations and references should be formatted according to current APA guidelines. Milestone 2 & Milestone 3 attached for reference
Sample Paper For Above instruction
Title: Analyzing Key Elements of Immunization Policies and Stakeholders
In this paper, I will analyze the immunization issue by exploring stakeholder needs and interests, legal and policy considerations, stakeholder conflicts, and legal risks. Building upon previous milestones, this comprehensive analysis offers insights into the complexities surrounding immunization policies and practices.
Stakeholder Needs and Interests
Key stakeholders involved in immunization include patients, healthcare providers, public health officials, policymakers, and pharmaceutical companies. Patients primarily seek protection from preventable diseases, while healthcare providers aim to increase vaccination coverage and prevent outbreaks. Public health officials are interested in achieving herd immunity and controlling disease spread, whereas policymakers focus on developing effective immunization policies that balance public safety with individual rights. Pharmaceutical companies are motivated by profits and the development of vaccines.
For example, parents' interests in vaccine safety may conflict with public health goals aimed at maximizing vaccination coverage. Healthcare providers often face ethical dilemmas when vaccine hesitancy occurs among certain populations, affecting immunization rates.
Legal and Policy Frameworks
Current healthcare laws, such as the National Childhood Vaccine Injury Act (NCVIA), regulate vaccine manufacturing and administration to ensure safety and efficacy. Policies promoting mandatory immunizations for school entry have legal backing, but they also raise questions about personal freedom and religious exemptions. Financially, vaccination programs are supported by government funding, insurance reimbursements, and private payments, with potential cost savings from reduced disease burden outweighing vaccination costs.
For example, the Vaccines for Children program provides free vaccines to eligible populations, demonstrating federal commitment to coverage and disease prevention.
Stakeholder Value Conflicts
Value conflicts often arise between individual rights and public health interests. Parents may oppose vaccination mandates due to religious or philosophical beliefs, leading to conflicts with public health objectives. Healthcare providers may struggle to balance respecting patient autonomy with advocating for community health. These conflicts can hinder immunization efforts and pose ethical challenges, emphasizing the need for policies that respect individual choices while safeguarding public health.
Such conflicts also extend to policymakers, who must consider societal benefits versus individual freedoms when designing immunization laws.
Legal Risks and Malpractice Issues
Legal risks associated with immunization include potential liability claims from adverse vaccine reactions. The National Vaccine Injury Compensation Program (VICP) provides a no-fault mechanism for compensating vaccine-related injuries, reducing litigation. However, conflicts over vaccine safety and efficacy can lead to malpractice claims against healthcare providers if improperly administered or if adverse events occur.
Conflicting values, such as the need to maximize vaccination coverage versus respecting personal beliefs, influence legal risks. Providers must navigate informed consent procedures carefully to minimize malpractice risks while adhering to legal mandates for immunization.
In conclusion, immunization policies encompass a complex interplay of stakeholder needs, legal frameworks, and ethical considerations. Understanding these elements fosters better strategies for promoting vaccination while respecting individual rights and minimizing legal risks.
References
- Centers for Disease Control and Prevention (CDC). (2023). Vaccines and Immunizations. https://www.cdc.gov/vaccines/index.html
- Omer, S. B., Salmon, D. A., Orenstein, W. A., deHart, M. P., & Massee, U. (2019). Vaccine Refusal, Mandatory Immunization, and the Risks of Vaccine-Preventable Diseases. New England Journal of Medicine, 360(19), 1981–1988.
- Hofmann, D. K., & Reimer, J. K. (2020). Legal and ethical considerations in vaccine policy. Journal of Law, Medicine & Ethics, 48(2), 247–256.
- U.S. Department of Health & Human Services. (2022). National Vaccine Injury Compensation Program. https://www.hrsa.gov/vaccine-compensation/index.html
- Larson, H. J., et al. (2019). The State of Vaccine Confidence 2019: A Global Perspective. The Lancet, 394(10182), 764–775.
- World Health Organization. (2020). Immunization Agenda 2030. https://www.who.int/immunization/en/
- Glanz, J. M., et al. (2019). Legal and Ethical Aspects of Vaccination. Pediatrics, 144(2), e20192752.
- Hinman, A. R., et al. (2021). Addressing Ethical and Legal Issues in Vaccine Policy. Vaccine, 39(43), 6154–6160.
- Thompson, R. N. (2020). The Impact of Vaccine Policies on Public Health. International Journal of Epidemiology, 49(2), 601–603.
- Roush, S. W., & Murphy, T. V. (2020). Vaccine-Preventable Diseases and Immunization Policy. MMWR Recommendations and Reports, 69(1), 1–20.